Centessa Beats Shareholder Suit Over Kidney Drug

By Katryna Perera · August 5, 2024, 4:48 PM EDT

A New York federal judge has tossed a shareholder lawsuit alleging that Centessa Pharmaceuticals PLC overstated the prospects of its kidney disease treatment ahead of the drugmaker's initial public offering, saying...

To view the full article, register now.

Documents

Case Information

Case Title

Jamia Fernandes v. Centessa Pharmaceuticals PLC et al

Case Number

1:22-cv-08805

Court

New York Southern

Nature of Suit

Securities/Commodities

Date Filed

October 15, 2022